These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2140331)

  • 41. Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectiveness.
    Maesen FP; Davies BI; Brouwers J; Rubingh G
    Eur J Respir Dis; 1982 Jul; 63(4):325-9. PubMed ID: 6981522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
    Poirier R
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis.
    Van Royen P; Betz W; Heyrman J; Taziaux P; Van den Haute M; Poelman M
    J Int Med Res; 1997; 25(1):33-40. PubMed ID: 9027671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of Clarithromycin in the treatment of acute mild to moderate respiratory tract infections.
    O'Neill SJ; Millar ED; Coles SJ; Bachand RT
    Ir Med J; 1991 Mar; 84(1):33-5. PubMed ID: 1828461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A; Longest KA; Senetar JE; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study.
    Davies BI; Maesen FP; Gubbelmans R
    J Antimicrob Chemother; 1989 May; 23(5):743-51. PubMed ID: 2547747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
    Anderson G; Esmonde TS; Coles S; Macklin J; Carnegie C
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():117-24. PubMed ID: 1827098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical efficacy and safety of spiramycin and clarithromycin in the treatment of outpatients with lower respiratory tract infections].
    Bocheńska-Marciniak M; Kupryś I; Krzywiecki A; Sliwowski A; Kuna P
    Pol Arch Med Wewn; 1998 Sep; 100(3):222-35. PubMed ID: 10335027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis.
    Adam D
    Infection; 1993; 21(4):265-71. PubMed ID: 8225636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032.
    Morimoto S; Nagate T; Sugita K; Ono T; Numata K; Miyachi J; Misawa Y; Yamada K; Omura S
    J Antibiot (Tokyo); 1990 Mar; 43(3):295-305. PubMed ID: 2139023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview.
    Hardy DJ; Guay DR; Jones RN
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):39-53. PubMed ID: 1530914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerance of enteric-coated erythromycin base (Ery-Max) administered twice or four times daily in patients with acute bronchitis.
    Pekkanen PS; Josefsson K
    J Int Med Res; 1983; 11(5):285-8. PubMed ID: 6642069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative efficacy of ciprofloxacin versus josamycin in the treatment of acute, recurrent, or exacerbated bronchitis.
    Canton P; Hoen B; Richet H; Ravoire S; Acar JF
    Am J Med; 1989 Nov; 87(5A):121S-122S. PubMed ID: 2589354
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.
    Wenzel RP; Hendley JO; Dodd WK; Gwaltney JM
    Antimicrob Agents Chemother; 1976 Dec; 10(6):899-901. PubMed ID: 795375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The tolerance and toxicity of clarithromycin.
    Wood MJ
    J Hosp Infect; 1991 Sep; 19 Suppl A():39-46. PubMed ID: 1684982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of ampicillin, erythromycin and erythromycin with sulphametopyrazine in the treatment of infective exacerbations of chronic bronchitis.
    Willey RF; Gould JC; Grant IW
    Br J Dis Chest; 1978 Jan; 72(1):13-20. PubMed ID: 341951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunostimulation by clarithromycin in healthy volunteers and chronic bronchitis patients.
    Scaglione F; Ferrara F; Dugnani S; Demartini G; Triscari F; Fraschini F
    J Chemother; 1993 Aug; 5(4):228-32. PubMed ID: 8229150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy of intramuscular injection of Xiyanping injection for the treatment of acute bronchitis in children: a multicenter, randomized, parallel-controlled clinical study].
    Chen Q; Zhu XH; Liu Y; Li L; Luo JH; Zhang YY; Huang J; Cao XC; Song XH; Wan FR
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Nov; 25(11):1107-1112. PubMed ID: 37990453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis].
    Takeda H; Miura H; Kawahira M; Kobayashi H; Otomo S; Nakaike S
    Kansenshogaku Zasshi; 1989 Jan; 63(1):71-8. PubMed ID: 2526188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.